ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021
Four-Factor Score for Outcome of Ibrutinib Treatment in Chronic Lymphocytic Leukemia: Prognostic Model for Risk Group Definition.
Stephan StilgenbauerPubMed ↗Publisher ↗
No numbers read from the abstract.